Propranolol    (DrugBank: Propranolol)

5 diseases
IDDisease name (Link within this page)Number of trials
6Parkinson disease0
158Tuberous sclerosis1
167Marfan syndrome1
227Osler disease1
278Huge lymphatic malformation with cervicofacial lesion1

6. Parkinson disease    [ 2,123 clinical trials,   2,046 drugs,   (DrugBank: 324 drugs),   183 drug target genes,   198 drug target pathways]
Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 2,123 trial found

158. Tuberous sclerosis    [ 100 clinical trials,   62 drugs,   (DrugBank: 16 drugs),   35 drug target genes,   115 drug target pathways]
Searched query = "Tuberous sclerosis", "Tuberous sclerosis complex"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 100 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02104011
(ClinicalTrials.gov)
May 22, 20151/4/2014Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockersTreatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers: Pilot TrialRenal Angiomyolipomas;Tuberous SclerosisDrug: PropranololUniversity Hospital, BordeauxNULLCompleted18 YearsN/AAll2Phase 2France

167. Marfan syndrome    [ 19 clinical trials,   38 drugs,   (DrugBank: 10 drugs),   10 drug target genes,   49 drug target pathways]
Searched query = "Marfan syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 19 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00651235
(ClinicalTrials.gov)
February 20073/3/2008A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan SyndromeA Randomized, Open-label, Active Control Trial to Evaluate the Effect of LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan SyndromeMarfan SyndromeDrug: Losartan and Atenolol or Propranolol;Drug: Atenolol or PropranololNational Taiwan University HospitalNULLRecruiting1 YearN/ABoth44Phase 2Taiwan

227. Osler disease    [ 49 clinical trials,   69 drugs,   (DrugBank: 21 drugs),   23 drug target genes,   132 drug target pathways]
Searched query = "Osler disease", "Hereditary hemorrhagic telangiectasia", "Osler-Weber-Rendu disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 49 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04113187
(ClinicalTrials.gov)
June 23, 202027/9/2019Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia PatientsStudy of the Efficacy of Propranolol for the Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia PatientsHereditary Hemorrhagic Telangiectasia;Osler Weber Rendu DiseaseDrug: Propranolol treatment;Drug: PlaceboUniversity Hospital, BordeauxAMRO-HHT-France - Association Maladie de Rendu-OslerRecruiting18 YearsN/AAll38Phase 3France

278. Huge lymphatic malformation with cervicofacial lesion    [ 19 clinical trials,   23 drugs,   (DrugBank: 7 drugs),   5 drug target genes,   62 drug target pathways]
Searched query = "Huge lymphatic malformation with cervicofacial lesion", "Huge lymphatic malformation", "Lymphatic malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 19 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000008498
2012/07/2524/07/2012Propranolol for a treatment of lymphatic malformation lymphatic malformationpropranolol therapyUniversity of TokyoNULLComplete: follow-up completeNot applicable65years-oldMale and Female20Phase 2Japan